We are monitoring the impact of COVID-19 on Asia Pacific Stem Cell Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 1025
Share on
Share on

Asia Pacific Stem Cell Market Research Report - Segmented By Mode Of Treatment, Applications, Technology, Type & By Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 1025
Pages: 136

APAC Stem Cell Market Size (2021 to 2026)

The size of the Asia Pacific Stem Cell Market is forecasted to grow USD 3641.00 million in 2021. It is estimated to reach USD 5863.87 million by the end of 2026, with a CAGR of 10%, during the forecast period.

The growth of the market is mainly driven due to better regulatory support through encouraging government policies and increasing awareness among the public. In addition, the Asia-pacific stem cell market is invested in various research organizations and developments of the stem cell industry. Innovation and implementation of multiple technologies and increasing population continuously in this region enhance the market's demand.

The stem cell market expansion in the APAC region is further driven by improved regulatory support, including promoting government initiatives and raising public awareness. Furthermore, the Asia Pacific stem cell market invests in various stem cell research organizations and innovations. As a result, the market demand is being boosted by innovation and the adoption of numerous technologies, and an ever-increasing population in this area.

The increased quality of differentiated cells resulting from efficient manufacturing as a result of partnerships is anticipated to expand the stem cell market's potential possibilities. Furthermore, during the projection period, the market would benefit from integrating several sectors such as materials, devices, chemical compounds, and biologics. In addition, favorable regulatory frameworks in emerging regions are projected to create substantial development possibilities for domestic and foreign companies in the stem cell manufacturing industry.

The cost of storing and maintaining stem cells is considerably higher, one of the most significant constraints in the stem cell industry. The research requires a significant amount of cash, and even a minor mistake in the research can be quite costly. In addition, it needs a highly qualified staff, which is extremely difficult to come by in today's market. Furthermore, the debate over research ethics and the complexity of the stem cell technique impacts market growth.

This research report on the APAC Stem Cell Market has been segmented and sub-segmented the Europe Stem Cell Market into the following categories:

By Treatment mode: 

  • Allogeneic
  • Autologous

By Cells Type: 

  • Adult Stem Cells
  • Induced Pluripotent Stem Cells
  • Human Embryonic Stem Cells
  • Others

By Technology: 

  • Cell Acquisition
  • Cell Production
  • Cryopreservation
  • Others

By Country: 

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Regionally, the APAC stem cell market is one of the fastest-growing regional markets in the global market. It is predicted to account for a substantial share in the global market during the forecast period. The stem cell market of India is anticipated to grow at the compound annual growth rate in upcoming years due to high awareness about stem cells, developments in tissue engineering, and increasing patients of chronic and genetic disorders. Also, the market has a substantial segment of pluripotent and embryonic products. Hence the market is growing this year. In addition, several companies are trying to develop new products in the market.

The Chinese stem cell market has the most significant growth in the Asia-pacific region. The presence of various diseases such as kidney, cardiac, hematological, diabetes mellitus, and osteoarthritis boosts the market's demand. Also, rapid development in stem cell therapy and its awareness is fuelling the Chinese market growth. China has applied for more stem cell patents for developments and continuous investment in the research and development of stem cells. The majority of key players are in China that accounted for the highest share of the stem cell market.

The stem cell market of Japan has projected to grow due to most of the prominent key players focuses on the development of gene therapy. Also, the Japanese health ministry approved fast-track stem cell therapy (Sterimac), and this treatment is available to Japanese people.

KEY MARKET PLAYERS:

Some of the Promising Companies Operating the Asia Pacific Stem Cell Market Profiled in the Report are Athersys, StemCells Inc, Cryo-Cell International, Geron Corporation, Mesoblast Ltd, Aastrom Biosciences Inc, Celgene Corporation, Invitrogen and Cytori Therapeutics Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By mode of treatment                           

                                5.1.1 Autologous             

                                5.1.2 Allogeneic

                5.2 By application                            

                                5.2.1 CNS            

                                5.2.2 CVS            

                                5.2.3 GIT             

                                5.2.4 Regenerative Medicine     

                                5.2.5 Musculoskeletal   

                                5.2.6 Eye & Immune System Development          

                                5.2.7 Blood Disorders    

                5.3 By technology                           

                                5.3.1 Cell Acquisition     

                                5.3.2 Cell Production     

                                5.3.3 Cryopreservation 

                                5.3.4 Expansion

                                5.3.5 Sub-Culture            

                5.4 By type                        

                                5.4.1 Adult Stem Cells   

                                5.4.2 Human Embryonic Cells     

                                5.4.3 Pluripotent Stem Cell          

                                5.4.4 Natural Rosette Cells          

6. Geographical Analysis                                              

                6.3 Asia-Pacific                 

                                6.1 Introduction              

                                6.2 China            

                                6.3 India              

                                6.4 Japan            

                                6.5 South Korea

                                6.6 Australia      

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Athersys                      

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 StemCells                    

                8.3 Cryo Cell International                           

                8.4 Geron Corporation                  

                8.5 Mesoblast                  

                8.6 Aastrom Biosciences                               

                8.7 Celgene Corporation                              

                8.8 Invitrogen                   

                8.9 Cytori Therapeutics                 

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

                                               

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Stem Cells Market By mode of treatment, From 2021 to 2026 (USD Billion)     
  2. Asia-Pacific Autologous Market By Region, From 2021 to 2026 (USD Billion)            
  3. Asia-Pacific Allogeneic Market By Region, From 2021 to 2026 (USD Billion)              
  4. Asia-Pacific Stem Cells Market By Application, From 2021 to 2026 (USD Billion)     
  5. Asia-Pacific CNS Market By Region, From 2021 to 2026 (USD Billion)          
  6. Asia-Pacific CVS Market By Region, From 2021 to 2026 (USD Billion)           
  7. Asia-Pacific GIT Market By Region, From 2021 to 2026 (USD Billion)            
  8. Asia-Pacific Regenerative Medicine Market By Region, From 2021 to 2026 (USD Billion)    
  9. Asia-Pacific Musculoskeletal Market By Region, From 2021 to 2026 (USD Billion)  
  10. Asia-Pacific Eye & Immune System Development Market By Region, From 2021 to 2026 (USD Billion)
  11. Asia-Pacific Blood Disorders Market By Region, From 2021 to 2026 (USD Billion)   
  12. Asia-Pacific Stem Cells Market By Technology, From 2021 to 2026 (USD Billion)     
  13. Asia-Pacific Cell Acquisition Market By Region, From 2021 to 2026 (USD Billion)    
  14. Asia-Pacific Cell Production Market By Region, From 2021 to 2026 (USD Billion)    
  15. Asia-Pacific Cryopreservation Market By Region, From 2021 to 2026 (USD Billion)
  16. Asia-Pacific Expansion Market By Region, From 2021 to 2026 (USD Billion)     
  17. Asia-Pacific Sub-Culture Market By Region, From 2021 to 2026 (USD Billion)           
  18. Asia-Pacific Stem Cells Market By type, From 2021 to 2026 (USD Billion)   
  19. Asia-Pacific Adult Stem Cells Market By Region, From 2021 to 2026 (USD Billion)  
  20. Asia-Pacific Human Embryonic Cells Market By Region, From 2021 to 2026 (USD Billion)   
  21. Asia-Pacific Pluripotent Stem Cell Market By Region, From 2021 to 2026 (USD Billion)
  22. Asia-Pacific Natural Rosette Cells Market By Region, From 2021 to 2026 (USD Billion)         
  23. Japan Stem Cells Market By mode of treatment, From 2021 to 2026 (USD Billion)
  24. Japan Stem Cells Market By Application, From 2021 to 2026 (USD Billion)
  25. Japan Stem Cells Market By Technology, From 2021 to 2026 (USD Billion)
  26. Japan Stem Cells Market By type, From 2021 to 2026 (USD Billion)              
  27. China Stem Cells Market By mode of treatment, From 2021 to 2026 (USD Billion) 
  28. China Stem Cells Market By Application, From 2021 to 2026 (USD Billion)
  29. China Stem Cells Market By Technology, From 2021 to 2026 (USD Billion)
  30. China Stem Cells Market By type, From 2021 to 2026 (USD Billion)              
  31. India Stem Cells Market By mode of treatment, From 2021 to 2026 (USD Billion)  
  32. India Stem Cells Market By Application, From 2021 to 2026 (USD Billion)  
  33. India Stem Cells Market By Technology, From 2021 to 2026 (USD Billion) 
  34. India Stem Cells Market By Type, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample